Vascular Disease and Thrombosis

My Settings
Relevant Content
State of Cardiovascular Disease and Stroke in Hispanic Latino Adults in the United States
This scientific statement reviews CVD epidemiology in Hispanic populations...
2026 Guideline for Adult Stroke Rehabilitation and Recovery
Stroke rehabilitation combines restorative and compensatory therapies to r...
Evidence Update for Minimally Invasive Surgical Evacuation of Supratentorial Spontaneous Intracerebral Hemorrhage
This science advisory reviews the latest randomized evidence on minimally...
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
Extension follow-up studies address long-term questions beyond the parent...
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Researchers at Heart
Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR): A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial
Stroke, Volume 57, Issue 8, Page 2295-2304, August 1, 2026.
BACKGROUN...
Tirofiban for Reduction of TEAR: A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial
Stroke, Ahead of Print.
BACKGROUND:Thromboembolism is a common compli...
Activation of HIF2 in Cardiac Vasculature Leads to Arterial Remodeling, Dilation, Thrombosis, and Inflammation, Recapitulating Cardiac Involvement in Kawasaki Disease
Circulation, Ahead of Print.
BACKGROUND:GlobalVhlknockout results in...
Thrombus and Aortic Wall 18F-FDG Positron Emission Tomography Uptake in Abdominal Aortic Aneurysms
Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print.
B...